サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1552940

生検装置の市場規模、シェア、動向分析レポート：製品別、地域別、セグメント予測、2024年～2030年

Biopsy Devices Market Size, Share & Trends Analysis Report By Product (Needle-based Biopsy Guns, Biopsy Guidance Systems, Biopsy Forceps, Biopsy Needles), By Region, And Segment Forecasts, 2024 - 2030

出版日
ページ情報
英文 100 Pages
納期
2～10営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
生検装置の市場規模、シェア、動向分析レポート：製品別、地域別、セグメント予測、2024年～2030年
出版日: 2024年08月09日
発行: Grand View Research
ページ情報: 英文 100 Pages
納期: 2～10営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

生検装置市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、生検装置の世界市場規模は2024年から2030年にかけてCAGR 7.2％で拡大し、2030年には36億4,000万米ドルに達すると予測されています。

技術的に先進的な製品のイントロダクションが、低侵襲外科手術の採用増加につながり、市場を牽引する主要因となっています。

また、政府や非政府組織による腫瘍学分野への投資の拡大は、市場成長にプラスの影響を与えると予測されています。例えば、2022年に米国がん研究所は、がんのない未来を確実にするための研究に1億1,000万米ドル以上の資金を提供しました。さらに、同組織は、がんおよび生物医学研究の翻訳を加速させることに焦点を当てたAdvanced Research Projects Agency for Health（ARPA-H）の設立を支援しています。

COVID-19パンデミックは、特にパンデミックの前半に生検手技の大幅な減少をもたらしました。これは生検装置の売上に一時的なマイナスの影響を与えました。この緩やかな売上減少の主な要因は、ウイルス感染を避けるための予防措置としてヘルスケア機関を訪れる患者の減少でした。

経済が正常化し、ヘルスケア部門ががん研究に重点を置くようになったことで、市場は急ピッチで回復しました。生検市場は、腫瘍学と診断学の分野における絶え間ない進歩により、予測期間中に大きな成長を遂げることがさらに期待されています。

生検装置市場レポートハイライト

  • 2023年には、軟部組織からのサンプル採取を目的としたこれらの機器に対する需要の急増により、針式生検ガンが最大の市場シェアを占めました。
  • 真空アシスト生検装置の新製品発売により、予測期間中、針式生検銃の需要がさらに加速すると予想されます。
  • 生検針セグメントは予測期間中に大きなCAGRを記録すると予想されます。これらの製品の採用が増加し、先進的な製品が発売されるため、有利な成長機会となります。
  • 北米は、技術的に先進的な製品の普及率が高く、主要な市場プレーヤーが存在するため、2023年の市場を独占しました。
  • がんの罹患率の上昇とアンメットニーズの高さが相まって、アジア太平洋地域における市場の成長を幅広く促進すると予想されます。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 生検装置市場の変数、動向、範囲

  • 市場系統の見通し
    • 親市場の見通し
    • 関連/付随市場の見通し
  • 浸透と成長の見込みマッピング
  • 業界バリューチェーン分析
    • 償還枠組み
  • 市場力学
    • 市場牽引要因分析
    • 市場抑制要因分析
  • 生検装置市場分析ツール
    • 業界分析- ポーターのファイブフォース分析
    • PESTEL分析
    • 主要取引と戦略的提携の分析
    • 市場参入戦略

第4章 生検装置：製品別推定・動向分析

  • 定義と範囲
    • 針式生検ガン
    • 生検ガイダンスシステム
    • 生検針
    • 生検鉗子
    • その他
  • 製品別：市場シェア、2022年および2030年
  • セグメントダッシュボード
  • 製品別：世界の生検装置市場展望
  • 2018年から2030年までの市場製品と予測および動向分析
    • 針式バイオプシーガン
    • 生検ガイダンスシステム
    • 生検針
    • 生検鉗子
    • その他

第5章 生検装置市場：地域別推定・動向分析

  • 地域別：市場シェア分析、2022年および2030年
  • 地域市場ダッシュボード
  • 世界の地域市場スナップショット
  • 地域別：市場シェアと主要プレーヤー、2022年
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東およびアフリカ
  • SWOT分析、要因別（政治・法律、経済・技術）
    • 北米
    • 欧州
    • アジア太平洋
    • ラテンアメリカ
    • 中東およびアフリカ
  • 市場製品、予測、動向分析、2018年から2030年
  • 北米
    • 米国
    • カナダ
  • 欧州
    • 英国
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • デンマーク
    • スウェーデン
    • ノルウェー
  • アジア太平洋
    • 日本
    • インド
    • 中国
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • アルゼンチン
  • 中東・アフリカ
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦
    • クウェート

第6章 競合情勢

  • 主要市場参入企業による最近の動向と影響分析
  • 企業/競合の分類
    • イノベーター
    • マーケットリーダー
    • 新興プレーヤー
  • ベンダー情勢
    • 主要販売代理店およびチャネルパートナーのリスト
    • 主要顧客
    • 主要企業の市場シェア分析、2022年
    • Cardinal Health Inc.
    • Hologic, Inc.
    • Danaher Corporation
    • CONMED Corporation
    • Cook Medical
    • DTR Medical
    • INRAD, Inc.
    • Devicor Medical Products Inc.
    • Gallini Srl
    • TransMed7, LLC
図表

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America biopsy devices market, by region, 2018 - 2030 (USD Million)
  • Table 3 North America biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 4 U.S. biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 5 Canada biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 6 Europe biopsy devices market, by region, 2018 - 2030 (USD Million)
  • Table 7 Europe biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 8 Germany biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 9 U.K. biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 10 France biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 11 Italy biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 12 Spain biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 13 Denmark biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 14 Sweden biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 15 Norway biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 16 APAC biopsy devices market, by region, 2018 - 2030 (USD Million)
  • Table 17 APAC biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 18 Japan biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 19 India biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 20 China biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 21 South Korea biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 22 Thailand biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 23 Australia biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 24 Latin America biopsy devices market, by region, 2018 - 2030 (USD Million)
  • Table 25 Latin America biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 26 Brazil biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 27 Mexico biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 28 Argentina biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 29 Middle East and Africa biopsy devices market, by region, 2018 - 2030 (USD Million)
  • Table 30 Middle East and Africa biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 31 South Africa biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 32 Saudi Arabia biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 33 UAE biopsy devices market, by product, 2018 - 2030 (USD Million)
  • Table 34 Kuwait biopsy devices market, by product, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Primary interviews in North America
  • Fig. 5 Primary interviews in Europe
  • Fig. 6 Primary interviews in APAC
  • Fig. 7 Primary interviews in Latin America
  • Fig. 8 Primary interviews in MEA
  • Fig. 9 Market research approaches
  • Fig. 10 Value-chain-based sizing & forecasting
  • Fig. 11 QFD modeling for market share assessment
  • Fig. 12 Market formulation & validation
  • Fig. 13 Biopsy devices: market outlook
  • Fig. 14 Biopsy devices market competitive insights
  • Fig. 15 Parent market outlook
  • Fig. 16 Related/ancillary market outlook
  • Fig. 17 Penetration and growth prospect mapping
  • Fig. 18 Industry value chain analysis
  • Fig. 19 Biopsy devices market driver impact
  • Fig. 20 Biopsy devices market restraint impact
  • Fig. 21 Biopsy devices market strategic initiatives analysis
  • Fig. 22 Biopsy devices market: product movement analysis
  • Fig. 23 Biopsy devices market: product outlook and key takeaways
  • Fig. 24 Needle-based biopsy guns estimates and forecast, 2018 - 2030
  • Fig. 25 Vacuum-assisted biopsy (VAB) devices estimates and forecast, 2018 - 2030
  • Fig. 26 Fine needle aspiration biopsy (FNAB) devices estimates and forecast, 2018 - 2030
  • Fig. 27 Core needle biopsy (CNB) devices estimates and forecast, 2018 - 2030
  • Fig. 28 Biopsy guidance systems estimates and forecast, 2018 - 2030
  • Fig. 29 Manual guidance systems estimates and forecast, 2018 - 2030
  • Fig. 30 Robotic guidance systems estimates and forecast, 2018 - 2030
  • Fig. 31 Biopsy needles estimates and forecast, 2018 - 2030
  • Fig. 32 Disposable needles estimates and forecast, 2018 - 2030
  • Fig. 33 Reusable needles estimates and forecast, 2018 - 2030
  • Fig. 34 Biopsy forceps estimates and forecast, 2018 - 2030
  • Fig. 35 General biopsy forceps estimates and forecast, 2018 - 2030
  • Fig. 36 Hot biopsy forceps estimates and forecast, 2018 - 2030
  • Fig. 37 Others estimates and forecast, 2018 - 2030
  • Fig. 38 Brushes market: regional movement analysis
  • Fig. 39 Curettes estimates and forecast, 2018 - 2030
  • Fig. 40 Punches estimates and forecast, 2018 - 2030
  • Fig. 41 Global Biopsy devices market: regional outlook and key takeaways
  • Fig. 42 Global market share and leading players
  • Fig. 43 North America market share and leading players
  • Fig. 44 Europe market share and leading players
  • Fig. 45 Asia Pacific market share and leading players
  • Fig. 46 Latin America market share and leading players
  • Fig. 47 Middle East & Africa market share and leading players
  • Fig. 48 North America: SWOT
  • Fig. 49 Europe SWOT
  • Fig. 50 Asia Pacific SWOT
  • Fig. 51 Latin America SWOT
  • Fig. 52 MEA SWOT
  • Fig. 53 North America, by country
  • Fig. 54 North America
  • Fig. 55 North America market estimates and forecast, 2018 - 2030
  • Fig. 56 U.S.
  • Fig. 57 U.S. market estimates and forecast, 2018 - 2030
  • Fig. 58 Canada
  • Fig. 59 Canada market estimates and forecast, 2018 - 2030
  • Fig. 60 Europe
  • Fig. 61 Europe market estimates and forecast, 2018 - 2030
  • Fig. 62 U.K.
  • Fig. 63 U.K. market estimates and forecast, 2018 - 2030
  • Fig. 64 Germany
  • Fig. 65 Germany market estimates and forecast, 2018 - 2030
  • Fig. 66 France
  • Fig. 67 France market estimates and forecast, 2018 - 2030
  • Fig. 68 Italy
  • Fig. 69 Italy market estimates and forecast, 2018 - 2030
  • Fig. 70 Spain
  • Fig. 71 Spain market estimates and forecast, 2018 - 2030
  • Fig. 72 Denmark
  • Fig. 73 Denmark market estimates and forecast, 2018 - 2030
  • Fig. 74 Sweden
  • Fig. 75 Sweden market estimates and forecast, 2018 - 2030
  • Fig. 76 Norway
  • Fig. 77 Norway market estimates and forecast, 2018 - 2030
  • Fig. 78 Asia Pacific
  • Fig. 79 Asia Pacific market estimates and forecast, 2018 - 2030
  • Fig. 80 Japan
  • Fig. 81 Japan market estimates and forecast, 2018 - 2030
  • Fig. 82 India
  • Fig. 83 India market estimates and forecast, 2018 - 2030
  • Fig. 84 China
  • Fig. 85 China market estimates and forecast, 2018 - 2030
  • Fig. 86 South Korea
  • Fig. 87 South Korea market estimates and forecast, 2018 - 2030
  • Fig. 88 Thailand
  • Fig. 89 Thailand market estimates and forecast, 2018 - 2030
  • Fig. 90 Australia
  • Fig. 91 Australia market estimates and forecast, 2018 - 2030
  • Fig. 92 Latin America
  • Fig. 93 Latin America market estimates and forecast, 2018 - 2030
  • Fig. 94 Brazil
  • Fig. 95 Brazil market estimates and forecast, 2018 - 2030
  • Fig. 96 Mexico
  • Fig. 97 Mexico market estimates and forecast, 2018 - 2030
  • Fig. 98 Argentina
  • Fig. 99 Argentina market estimates and forecast, 2018 - 2030
  • Fig. 100 Middle East and Africa
  • Fig. 101 Middle East and Africa market estimates and forecast, 2018 - 2030
  • Fig. 102 South Africa
  • Fig. 103 South Africa market estimates and forecast, 2018 - 2030
  • Fig. 104 Saudi Arabia
  • Fig. 105 Saudi Arabia market estimates and forecast, 2018 - 2030
  • Fig. 106 UAE
  • Fig. 107 UAE market estimates and forecast, 2018 - 2030
  • Fig. 108 Kuwait
  • Fig. 109 Kuwait market estimates and forecast, 2018 - 2030
  • Fig. 110 Participant categorization- Biopsy devices market
  • Fig. 111 Market share of key market players - Biopsy devices market
目次
Product Code: 978-1-68038-034-7

Biopsy Devices Market Growth & Trends:

The global biopsy devices market size is projected to reach USD 3.64 billion by 2030, expanding at a CAGR of 7.2% from 2024 to 2030, according to a new report by Grand View Research, Inc. Introduction of technologically advanced products, leading to increasing adoption of minimally invasive surgical procedures, is the key factor driving the market.

In addition, growing investments in the oncology field by government and non-government organizations are expected to positively impact market growth. For instance, in 2022, the American Institute for Cancer Research funded more than $110 million for research to ensure a future without cancer. Moreover, the organization supports the establishment of an Advanced Research Projects Agency for Health (ARPA-H) that is focused on accelerating cancer and biomedical research translation.

The COVID-19 pandemic led to a significant drop in biopsy procedures, especially in the first half of the pandemic. This represented a temporary negative impact on the sales of biopsy devices. The major factor responsible for this moderate downfall in sales was reduced patient visits to healthcare institutes as a precautionary measure to avoid being infected with the virus.

With economies returning to normalcy and the healthcare sector going back to majorly focusing on cancer research, the market recovered at a rapid pace. The biopsy market is further expected to witness significant growth over the forecast period due to constant advancements in the field of oncology and diagnostics.

Biopsy Devices Market Report Highlights:

  • Needle-based biopsy guns held the largest market share in 2023 owing to surging demand for these devices to acquire samples from soft tissues
  • New product launches of vacuum-assisted biopsy devices are further expected to accelerate the demand for needle-based biopsy guns over the forecast period
  • The biopsy needles segment is expected to register a significant CAGR over the forecast period. It represents lucrative growth opportunities owing to the increasing adoption of these products and the launch of advanced products
  • North America dominated the market in 2023 due to the high penetration rate of technologically advanced products and the presence of key market players in the region
  • The rising incidence of cancer coupled with high unmet patient needs is expected to propel the growth of the market extensively in the Asia Pacific region

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Product
    • 1.1.2. Regional scope
    • 1.1.3. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for primary interviews in North America
      • 1.3.5.2. Data for primary interviews in Europe
      • 1.3.5.3. Data for primary interviews in Asia Pacific
      • 1.3.5.4. Data for primary interviews in Latin America
      • 1.3.5.5. Data for Primary interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.2. Approach 1: Commodity flow approach
    • 1.6.3. Volume price analysis (Model 2)
    • 1.6.4. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives
    • 1.9.1. Objective 1
    • 1.9.2. Objective 2

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Product Outlook
    • 2.2.2. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Biopsy Devices Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Industry Value Chain Analysis
    • 3.3.1. Reimbursement framework
  • 3.4. Market Dynamics
    • 3.4.1. Market driver analysis
      • 3.4.1.1. Increasing prevalence of cancer
      • 3.4.1.2. Growing demand for minimally invasive medical procedures
      • 3.4.1.3. New product launches
    • 3.4.2. Market restraint analysis
      • 3.4.2.1. High cost of products
  • 3.5. Biopsy Devices Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Supplier power
      • 3.5.1.2. Buyer power
      • 3.5.1.3. Substitution threat
      • 3.5.1.4. Threat of new entrant
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political landscape
      • 3.5.2.2. Technological landscape
      • 3.5.2.3. Economic landscape
    • 3.5.3. Major Deals & Strategic Alliances Analysis
    • 3.5.4. Market Entry Strategies

Chapter 4. Biopsy Devices: Product Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Needle-based Biopsy Guns
    • 4.1.2. Biopsy Guidance Systems
    • 4.1.3. Biopsy Needles
    • 4.1.4. Biopsy Forceps
    • 4.1.5. Others
  • 4.2. Product Market Share, 2022 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Biopsy Devices Market by Product Outlook
  • 4.5. Market Product& Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Needle-based Biopsy Guns
      • 4.5.1.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
      • 4.5.1.2. Vacuum-assisted Biopsy (VAB) Devices
        • 4.5.1.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
      • 4.5.1.3. Fine Needle Aspiration Biopsy (FNAB) Devices
        • 4.5.1.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
      • 4.5.1.4. Core Needle Biopsy (CNB) devices
        • 4.5.1.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
    • 4.5.2. Biopsy Guidance Systems
      • 4.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
      • 4.5.2.2. Manual
        • 4.5.2.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
      • 4.5.2.3. Robotic
        • 4.5.2.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
    • 4.5.3. Biopsy Needles
      • 4.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
      • 4.5.3.2. Disposable
        • 4.5.3.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
      • 4.5.3.3. Reusable
        • 4.5.3.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
    • 4.5.4. Biopsy Forceps
      • 4.5.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
      • 4.5.4.2. General Biopsy Forceps
        • 4.5.4.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
      • 4.5.4.3. Hot Biopsy Forceps
        • 4.5.4.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
    • 4.5.5. Others
      • 4.5.5.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
      • 4.5.5.2. Brushes
        • 4.5.5.2.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
      • 4.5.5.3. Curettes
        • 4.5.5.3.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)
      • 4.5.5.4. Punches
        • 4.5.5.4.1. Market estimates and forecast, 2018 - 2030 (Revenue in USD Million)

Chapter 5. Biopsy Devices Market: Regional Estimates & Trend Analysis

  • 5.1. Regional market share analysis, 2022 & 2030
  • 5.2. Regional Market Dashboard
  • 5.3. Global Regional Market Snapshot
  • 5.4. Regional Market Share and Leading Players, 2022
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East and Africa
  • 5.5. SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
    • 5.5.1. North America
    • 5.5.2. Europe
    • 5.5.3. Asia Pacific
    • 5.5.4. Latin America
    • 5.5.5. Middle East and Africa
  • 5.6. Market Product, & Forecasts and Trend Analysis, 2018 to 2030
  • 5.7. North America
    • 5.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.7.2. U.S.
      • 5.7.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.7.3. Canada
      • 5.7.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 5.8. Europe
    • 5.8.1. U.K.
      • 5.8.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.8.2. Germany
      • 5.8.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.8.3. France
      • 5.8.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.8.4. Italy
      • 5.8.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.8.5. Spain
      • 5.8.5.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.8.6. Denmark
      • 5.8.6.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.8.7. Sweden
      • 5.8.7.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.8.8. Norway
      • 5.8.8.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 5.9. Asia Pacific
    • 5.9.1. Japan
      • 5.9.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.9.2. India
      • 5.9.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.9.3. China
      • 5.9.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.9.4. South Korea Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.9.5. Thailand Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.9.6. Australia Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 5.10. Latin America
    • 5.10.1. Brazil
      • 5.10.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.10.2. Mexico
      • 5.10.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.10.3. Argentina
      • 5.10.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
  • 5.11. MEA
    • 5.11.1. South Africa
      • 5.11.1.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.11.2. Saudi Arabia
      • 5.11.2.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.11.3. UAE
      • 5.11.3.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)
    • 5.11.4. Kuwait
      • 5.11.4.1. Market estimates and forecast, 2018 - 2030 (Revenue, USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 6.2. Company/Competition Categorization
    • 6.2.1. Innovators
    • 6.2.2. Market Leaders
    • 6.2.3. Emerging Players
  • 6.3. Vendor Landscape
    • 6.3.1. List of key distributors and channel partners
    • 6.3.2. Key customers
    • 6.3.3. Key company market share analysis, 2022
    • 6.3.4. Cardinal Health Inc.
      • 6.3.4.1. Company overview
      • 6.3.4.2. Financial performance
      • 6.3.4.3. Product benchmarking
      • 6.3.4.4. Strategic initiatives
    • 6.3.5. Hologic, Inc.
      • 6.3.5.1. Company overview
      • 6.3.5.2. Financial performance
      • 6.3.5.3. Product benchmarking
      • 6.3.5.4. Strategic initiatives
    • 6.3.6. Danaher Corporation
      • 6.3.6.1. Company overview
      • 6.3.6.2. Financial performance
      • 6.3.6.3. Product benchmarking
      • 6.3.6.4. Strategic initiatives
    • 6.3.7. CONMED Corporation
      • 6.3.7.1. Overview
      • 6.3.7.2. Financial performance
      • 6.3.7.3. Product benchmarking
      • 6.3.7.4. Strategic initiatives
    • 6.3.8. Cook Medical
      • 6.3.8.1. Company overview
      • 6.3.8.2. Financial performance
      • 6.3.8.3. Product benchmarking
      • 6.3.8.4. Strategic initiatives
    • 6.3.9. DTR Medical
      • 6.3.9.1. Company overview
      • 6.3.9.2. Financial performance
      • 6.3.9.3. Product benchmarking
      • 6.3.9.4. Strategic initiatives
    • 6.3.10. INRAD, Inc.
      • 6.3.10.1. Company overview
      • 6.3.10.2. Financial performance
      • 6.3.10.3. Product benchmarking
      • 6.3.10.4. Strategic initiatives
    • 6.3.11. Devicor Medical Products Inc.
      • 6.3.11.1. Company overview
      • 6.3.11.2. Financial performance
      • 6.3.11.3. Product benchmarking
      • 6.3.11.4. Strategic initiatives
    • 6.3.12. Gallini Srl
      • 6.3.12.1. Company overview
      • 6.3.12.2. Financial performance
      • 6.3.12.3. Product benchmarking
      • 6.3.12.4. Strategic initiatives
    • 6.3.13. TransMed7, LLC
      • 6.3.13.1. Company overview
      • 6.3.13.2. Financial performance
      • 6.3.13.3. Product benchmarking
      • 6.3.13.4. Strategic initiatives